Quadrature Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-88,805
Closed -$156K – 1655
2026
Q1
$156K Buy
88,805
+76,651
+631% +$166K ﹤0.01% 1164
2025
Q4
$28.6K Buy
+12,154
New +$33.2K ﹤0.01% 1197
2024
Q4
– Sell
-44,501
Closed -$125K – 1079
2024
Q3
$125K Sell
44,501
-305,800
-87% -$700K ﹤0.01% 834
2024
Q2
$434K Buy
+350,301
New +$314K 0.01% 705
2023
Q1
– Sell
-155,045
Closed -$144K – 962
2022
Q4
$144K Buy
+155,045
New +$207K ﹤0.01% 759
2022
Q3
– Sell
-45,498
Closed -$97K – 882
2022
Q2
$97K Sell
45,498
-578,901
-93% -$1.54M ﹤0.01% 666
2022
Q1
$2.22M Buy
+624,399
New +$1.81M 0.09% 178

Other funds holding CLOV

Quadrature Capital's CLOV Position: Q2 2026 in Review

Quadrature Capital sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 88,805 shares — an estimated $156K sold.

Quadrature Capital first reported a position in CLOV in Q1 2022 and held it in 7 quarters. The position peaked at $2.22M in Q1 2022. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Quadrature Capital reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 88,805 Clover Health Investments shares in Q2 2026, an estimated $156K.
  • Quadrature Capital first reported a position in Clover Health Investments in Q1 2022 and held it in 7 quarters.
  • Quadrature Capital's Clover Health Investments position peaked at $2.22M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.